Oxytocin in young children with Prader‐Willi syndrome: Results of a randomized, double‐blind, placebo‐controlled, crossover trial investigating 3 months of oxytocin-Reference-Cited by-同舟云学术

Oxytocin in young children with Prader‐Willi syndrome: Results of a randomized, double‐blind, placebo‐controlled, crossover trial investigating 3 months of oxytocin

Published:2020-12-21 Issue:5 Volume:94 Page:774-785
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:Clin Endocrinol

Author:

Damen Layla¹²³^ORCID,Grootjen Lionne N.¹²³,Juriaans Alicia F.¹²³,Donze Stephany H.¹²³^ORCID,Huisman T. Martin⁴,Visser Jenny A.⁴,Delhanty Patric J.D.⁴,Hokken‐Koelega Anita C.S.¹²³

Affiliation:

1. Dutch Growth Research Foundation Rotterdam the Netherlands

2. Department of Pediatrics Subdivision of Endocrinology Erasmus University Medical CenterSophia Children’s Hospital Rotterdam the Netherlands

3. Dutch Reference Center for Prader‐Willi Syndrome the Netherlands

4. Department of Internal Medicine Erasmus University Medical Center Rotterdam the Netherlands

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cen.14387

Reference44 articles.